These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9524297)

  • 1. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.
    Lu RH; Hwang SJ; Chan CY; Chang FY; Lee SD
    J Clin Lab Anal; 1998; 12(2):121-5. PubMed ID: 9524297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
    Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
    Pawlotsky JM; Martinot-Peignoux M; Poveda JD; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P
    J Virol Methods; 1999 May; 79(2):227-35. PubMed ID: 10381092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
    Veillon P; Payan C; Picchio G; Maniez-Montreuil M; Guntz P; Lunel F
    J Clin Microbiol; 2003 Jul; 41(7):3212-20. PubMed ID: 12843066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA.
    Nolte FS; Thurmond C; Fried MW
    J Clin Microbiol; 1995 Jul; 33(7):1775-8. PubMed ID: 7665645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
    Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
    J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus.
    Enomoto M; Nishiguchi S; Shiomi S; Tanaka M; Fukuda K; Ueda T; Tamori A; Habu D; Takeda T; Yano Y; Otani S
    J Gastroenterol Hepatol; 2001 Aug; 16(8):904-9. PubMed ID: 11555105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.
    Furusyo N; Hayashi J; Kashiwagi K; Nakashima H; Nabeshima S; Sawayama Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 2002 Mar; 47(3):535-42. PubMed ID: 11911338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the Amplicor HCV Monitor Test and the Quantiplex HCV RNA 2.0 assay (bDNA).
    Tong CY; Hollingsworth RC; Williams H; Irving WL; Gilmore IT
    J Med Virol; 1998 Jul; 55(3):191-6. PubMed ID: 9624605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.
    Beld M; Sentjens R; Rebers S; Weegink C; Weel J; Sol C; Boom R
    J Clin Microbiol; 2002 Mar; 40(3):788-93. PubMed ID: 11880394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
    Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM
    Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilaboratory comparison of hepatitis C virus viral load assays.
    Caliendo AM; Valsamakis A; Zhou Y; Yen-Lieberman B; Andersen J; Young S; Ferreira-Gonzalez A; Tsongalis GJ; Pyles R; Bremer JW; Lurain NS
    J Clin Microbiol; 2006 May; 44(5):1726-32. PubMed ID: 16672399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.
    Germer JJ; Heimgartner PJ; Ilstrup DM; Harmsen WS; Jenkins GD; Patel R
    J Clin Microbiol; 2002 Feb; 40(2):495-500. PubMed ID: 11825962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measurement of HCV RNA in the serum: a comparison of three assays based on different principles.
    Ichijo T; Matsumoto A; Kobayashi M; Furihata K; Tanaka E
    J Gastroenterol Hepatol; 1997 Jul; 12(7):500-6. PubMed ID: 9257240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.
    Gerken G; Rothaar T; Rumi MG; Soffredini R; Trippler M; Blunk MJ; Butcher A; Soviero S; Colucci G
    J Clin Microbiol; 2000 Jun; 38(6):2210-4. PubMed ID: 10834978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
    Gretch DR; dela Rosa C; Carithers RL; Willson RA; Williams B; Corey L
    Ann Intern Med; 1995 Sep; 123(5):321-9. PubMed ID: 7542853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of reverse transcription-polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment. Consensus Interferon Study Group.
    Pockros PJ; Bain VG; Hunter EB; Conrad A; Balart A; Hollinger FB; Albert D
    J Viral Hepat; 1999 Mar; 6(2):145-50. PubMed ID: 10607226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of viral loads in patients with chronic hepatitis C with AMPLICOR HCV MONITOR version 1.0, COBAS HCV MONITOR version 2.0, and QUANTIPLEX HCV RNA version 2.0 assays.
    Martinot-Peignoux M; Le Breton V; Fritsch S; Le Guludec G; Labouret N; Keller F; Marcellin P
    J Clin Microbiol; 2000 Jul; 38(7):2722-5. PubMed ID: 10878070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.